Resveratrol decreases the insoluble Aβ1-42 level in hippocampus and protects the integrity of the blood-brain barrier in AD rats
- PMID: 26454022
- DOI: 10.1016/j.neuroscience.2015.10.006
Resveratrol decreases the insoluble Aβ1-42 level in hippocampus and protects the integrity of the blood-brain barrier in AD rats
Abstract
Our previous studies demonstrated resveratrol (Res) administration protected Alzheimer's disease (AD) rats from developing memory decline by anti-oxidation. Beta-amyloid peptide 1-42 (Aβ1-42) is not only the primary protein component of senile plaques in AD but also is believed to play an important part in its pathology. Increasing evidence has shown neuroinflammation and the integrity of the blood-brain barrier (BBB) is closely related to the pathogenesis of AD. The aim of the present study is to further elucidate whether Res prevents AD rats from inflammation induced by Aβ1-42 and protects the integrity of BBB. Rats were divided into six groups: (1) ovariectomized (OVX)+D-galactose (D-gal) 100mg/kg group (OVX+D-gal); (2-4) OVX, D-gal and Res 20, 40 and 80 mg/kg treated groups; and (5) OVX, D-gal and estradiol valerate 0.8 mg/kg treated group (ET); (6) Sham control group. 12 weeks later, Res 40 and 80 mg/kg treatment exhibited a significant decrease of Aβ1-42 compared with the OVX+D-gal rats of hippocampus, which was accompanied by decreased expression of advanced glycation endproducts (RAGE), matrix metalloprotein-9 (MMP-9), nuclear factor kappaB (NF-κB) and the increase of Claudin-5. These results suggest that Res is useful not only in protecting OVX+D-gal rats from neuroinflammation mediated by Aβ1-42 by decreasing the expression of NF-κB but also the integrity of BBB by increasing Claudin-5 and decreasing RAGE, MMP-9.
Keywords: Claudin-5; beta-amyloid peptide 1–42; matrix metalloprotein-9; nuclear factor kappaB; receptor for advanced glycation endproducts; resveratrol.
Copyright © 2015 IBRO. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
Long-term resveratrol consumption protects ovariectomized rats chronically treated with D-galactose from developing memory decline without effects on the uterus.Brain Res. 2012 Jul 27;1467:67-80. doi: 10.1016/j.brainres.2012.05.040. Epub 2012 May 27. Brain Res. 2012. PMID: 22647751
-
1,25-Dihydroxyvitamin D3 regulates expression of LRP1 and RAGE in vitro and in vivo, enhancing Aβ1-40 brain-to-blood efflux and peripheral uptake transport.Neuroscience. 2016 May 13;322:28-38. doi: 10.1016/j.neuroscience.2016.01.041. Epub 2016 Jan 25. Neuroscience. 2016. PMID: 26820600
-
Long-term D-galactose injection combined with ovariectomy serves as a new rodent model for Alzheimer's disease.Life Sci. 2007 Apr 24;80(20):1897-905. doi: 10.1016/j.lfs.2007.02.030. Epub 2007 Mar 1. Life Sci. 2007. PMID: 17391708
-
Relevance of abeta1-42 intrahippocampal injection as an animal model of inflamed Alzheimer's disease brain.Curr Alzheimer Res. 2008 Oct;5(5):475-80. doi: 10.2174/156720508785908874. Curr Alzheimer Res. 2008. PMID: 18855589 Review.
-
Resveratrol and Amyloid-Beta: Mechanistic Insights.Nutrients. 2017 Oct 14;9(10):1122. doi: 10.3390/nu9101122. Nutrients. 2017. PMID: 29036903 Free PMC article. Review.
Cited by
-
An Appraisal of the Oleocanthal-Rich Extra Virgin Olive Oil (EVOO) and Its Potential Anticancer and Neuroprotective Properties.Int J Mol Sci. 2023 Dec 10;24(24):17323. doi: 10.3390/ijms242417323. Int J Mol Sci. 2023. PMID: 38139152 Free PMC article. Review.
-
Inflammatory Cascade in Alzheimer's Disease Pathogenesis: A Review of Experimental Findings.Cells. 2021 Sep 28;10(10):2581. doi: 10.3390/cells10102581. Cells. 2021. PMID: 34685563 Free PMC article. Review.
-
Advanced Glycation End Products in Health and Disease.Microorganisms. 2022 Sep 15;10(9):1848. doi: 10.3390/microorganisms10091848. Microorganisms. 2022. PMID: 36144449 Free PMC article. Review.
-
Maternal pomegranate juice intake and brain structure and function in infants with intrauterine growth restriction: A randomized controlled pilot study.PLoS One. 2019 Aug 21;14(8):e0219596. doi: 10.1371/journal.pone.0219596. eCollection 2019. PLoS One. 2019. PMID: 31433809 Free PMC article. Clinical Trial.
-
SIRT1 Is Involved in the Neuroprotection of Pterostilbene Against Amyloid β 25-35-Induced Cognitive Deficits in Mice.Front Pharmacol. 2022 Apr 14;13:877098. doi: 10.3389/fphar.2022.877098. eCollection 2022. Front Pharmacol. 2022. PMID: 35496289 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous